For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
National Review
Monkeypox Outbreak Leveling Off, No Thanks to Government
Something that apparently surprised government bureaucrats and left-wing commentators but is, in fact, completely predictable is happening: The growth in new monkeypox cases is leveling off…
The New York Post
Key to CDC reform is undoing mission creep — and tossing woke programs
Centers for Disease Control and Prevention Director Rochelle Walensky has finally admitted what has been obvious to most observers for 2½ years: The agency has been…
C-SPAN
Video: Senior Fellow Joel Zinberg Joins C-SPAN to Discuss Senate Democratic Health Care and Prescription Drug Proposals
Senior Fellow Joel Zinberg joined the Washington Journal to discuss Senate Democratic Health Care and Prescription Drug Proposals. Click here to read more.
City Journal
No More Masks
Covid-19 cases are on the rise again in the United States. Even President Biden is infected. But the biggest danger is not the virus—the now-dominant…
National Review
Regulators’ Misguided Crackdown on Nicotine Products and Their Makers
Federal agencies must really love black markets. Last week, the Food and Drug Administration (FDA) announced a plan to limit nicotine in cigarettes and …
Blog
The FTC vs. the Right to a Fair Trial
The Food and Drug Administration recently proposed capping the nicotine in cigarettes, which will encourage many smokers to smoke more to get the same nicotine…
